Is OCUL A Good Stock To Buy Now?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Ocular Therapeutix Inc (OCUL)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Opaleye Management James A. Silverman | 6,510,000 | $134,758 | +9% | 17.6% |
| 2. | Citadel Investment Group Ken Griffin | 1,588,874 | $32,889 | -3% | 0% |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 1,065,100 | $22,048 | +228% | 0.05% |
| 4. | D E Shaw D. E. Shaw | 1,049,746 | $21,730 | +285% | 0.01% |
| 5. | Great Point Partners Jeffrey Jay And David Kroin | 856,162 | $17,723 | 2.87% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.48 | 437 | Large Shareholder | 5,618,861 | 2020-10-16 | Filing | |
| $5.50 | 363,636 | Large Shareholder | 5,618,424 | 2020-05-19 | Filing | |
| $4.87 | 35,052 | Large Shareholder | 5,254,788 | 2020-03-24 | Filing | |
| $4.66 | 64,948 | Large Shareholder | 5,219,736 | 2020-03-23 | Filing | |
| $4.52 | 9,100 | Large Shareholder | 5,154,788 | 2020-03-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 25,000 | Director | 0 | 2020-12-03 | Filing | |
| $17.16 | 9,470 | Officer | 112,060 | 2015-09-15 | Filing | |
| $22.00 | 1,878 | Large Shareholder | 13,007 | 2015-06-15 | Filing | |
| $22.00 | 318,122 | Large Shareholder | 2,202,377 | 2015-06-15 | Filing | |
| $22.00 | 1,878 | Large Shareholder, Director | 13,007 | 2015-06-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 50,137 | $1,037,836 | 0% | |
| 2. | 13,369 | $276,738 | 0% | |
| 3. | 5,618,861 | $116,310 | 100% | |
| 4. | 5,512,264 | $114,103 | 0% | |
| 5. | 5,000 | $103,500 | 0.02% |
News See All
Should You Avoid Ocular Therapeutix Inc (OCUL)?
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...
Did Hedge Funds Drop The Ball On Ocular Therapeutix Inc (OCUL) ?
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and...
Chevron, Sprint, Ocular Therapeutix, and More: Why These Stocks Are in the Spotlight
All eyes are on the tech sector after President Trump escalated the trade war with China by putting Chinese crown jewel Huawei on a blacklist. Predictably, many tech names fell hard on the day and the...
Positive Results Reported For Ocular Therapeutix Inc (OCUL) Dextenza Following Phase III Study
Positive results for the Phase III study meant to test the experiences of patients using the eye insert known as Dextenza to relieve pain in a post-surgical situation have been recorded according to...
Biotech Movers And Shakers: Ocular Therapeutix Inc (OCUL) And Argos Therapeutics Inc (ARGS)
The biotechnology space has been a pretty volatile arena over the last few weeks, and especially when it comes to the smaller capitalization end of the sector. Companies have put out data both good and...
How Ocular Therapeutix Inc (OCUL) Stacks Up Against Its Peers
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards...
Here’s Why Amazon, Alphabet, Ocular Therapeutix, and Two Other Stocks Are Trending on Thursday
In this article, we will analyze the latest events surrounding Amazon.com, Inc. (NASDAQ:AMZN), United States Steel Corporation (NYSE:X), Alphabet Inc (NASDAQ:GOOG), Ocular Therapeutix Inc (NASDAQ:OCUL...
Why Adamis Pharmaceuticals, Immunomedics and Three Other Stocks Are Deep in Red Today?
Markets are trading higher on Monday, as HSBC Holdings PLC said in a report earlier today that the markets are poised to remain bullish. However, some stocks are deep in the red today, including Adamis...
David Lamond’s Top Healthcare and Technology Stock Picks
Founded in 2011, David Lamond's Lamond Capital Partners filed its first 13F form in 2012, when it held nearly $110 million in assets under management. As of April this year, its assets had swelled to $...
Billionaire Hedge Funds
